Laser-assisted delivery enhances topical uptake of the anticancer agent cisplatin
Systemic chemotherapy with the anticancer agent cisplatin is approved for advanced non-melanoma skin cancer (NMSC), but topical treatment is limited by insufficient cutaneous penetration. We studied the impact of ablative fractional laser (AFL) exposure on topical cisplatin’s pharmacokinetics and bi...
Main Authors: | Emily Wenande, Uffe H. Olesen, Malene R. Boesen, Daniel P. Persson, Catharina M. Lerche, Stefan Stürup, Bente Gammelgaard, Søren Husted, R. Rox Anderson, Merete Haedersdal |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2018.1534896 |
Similar Items
-
Fabrication and characterization of ruby nanoparticles
by: Hashim, A., et al.
Published: (2018) -
Upconversion nanoparticle as a theranostic agent for tumor imaging and therapy
by: Wenkai Fang, et al.
Published: (2016-07-01) -
Bleomycin administered by laser-assisted drug delivery or intradermal needle-injection results in distinct biodistribution patterns in skin: in vivo investigations with mass spectrometry imaging
by: Kristoffer Hendel, et al.
Published: (2021-01-01) -
Tailoring Photoluminescence from Si-Based Nanocrystals Prepared by Pulsed Laser Ablation in He-N<sub>2</sub> Gas Mixtures
by: Anastasiya A. Fronya, et al.
Published: (2020-01-01) -
Fractional laser-assisted topical delivery of bleomycin quantified by LC-MS and visualized by MALDI mass spectrometry imaging
by: Kristoffer K. Hendel, et al.
Published: (2019-01-01)